Our data, for the first time, indicate that COLO699 cells treated with NSCLC-PE-EVs decrease PDCD4 and PTEN gene expression, confirming the role of NSCLC-PE-EVs in LC cell proliferation and migration. This evidence concerns the gene PDCD4 and non-small cell lung carcinoma.